Sign in

or Register now

ADHDCentral.com

See all of our health sites at www.HealthCentral.com
Sunday, October, 25, 2009

New Adhd Drugs

New ADHD drug could treat symptoms for up to 16 hours

October 02, 2008
A new experimental drug to treat attention-deficit/hyperactivity disorder (ADHD) has shown positive results in its latest clinical trial. The drug, SPD465, is an amphetamine compound intended to treat ADHD in adults. The new study found that the drug improved ADHD symptoms in adults for up to 16 hours and was well tolerated by the study's participants. Read more »

Expert & Community Posts

1443
New Research Raises Questions About Long Term Effectiveness of ADHD Medications
By Eileen Bailey , Health Expert

...symptoms of ADHD.       Source:   [1] "Debate of Drugs for ADHD Reignites", 2007, Mar 27,... Read more »

8689
ADHD and Stimulants
By Deborah , Health Expert

At the end of my first year in college I did the usual exam week cramming. I don't test well (my... Read more »

8689
When to Give ADHD Medication a Shot & When to Stop It
By Deborah , Health Expert

So, as I said in my last SharePost, my son was recently diagnosed with Attention Deficit... Read more »

1443
FDA Recommends Continuing Medication Based on Limitations on New Study
By Eileen Bailey , Health Expert

ADHD medications are once again in the news this week. A study released this week indicated an... Read more »

1443
Adults with ADHD
By Eileen Bailey , Health Expert

What are some of the common symptoms of ADHD in adults?    Most information is written on... Read more »

Health Guide

ADHD Issues: How is Attention Deficit Hyperactivity Disorder (ADHD) treated?
ADHD and childhood behavioral disorders are usually better treated in specialized education settings with behavioral management of the disruptive behavior. Whether the patient is an ADHD adult... Read more »
Attention-Deficit Hyperactivity Disorder: Medications
Several medications are available to treat ADHD.Psychostimulants: Methylphenidate (Ritalin) and Similar DrugsPsychostimulants are the primary drugs used to treat ADHD. Although these drugs... Read more »
Attention-Deficit Hyperactivity Disorder: Risk Factors
In the U.S., the number of diagnosed cases of ADHD in children increased from 1990 to 1996, from nearly 950,000 to over 2.4 million. As of 2004, about 4.5 million children between the... Read more »
ADHD Issues: What are the risk factors and causes of Attention Deficit Hyperactivity Disorder (ADHD)?">
The cause of ADHD seems to be neurobiological or genetic. Environmental factors influence the severity of the disorder, but environmental factors do not seem to give rise to the condition by... Read more »
ADHD Issues: What is Attention Deficit Hyperactivity Disorder (ADHD)?
Attention deficit hyperactivity disorder (ADHD) is one of the most common chronic psychiatric conditions diagnosed in childhood. Although thought of as a child's condition, adult ADHD is not... Read more »

Medications

Eon04040_115299_5

This combination medication is used as part of a total treatment program to control attention... Read more »

Related News

New ADHD drug, NRP104, shows promise in new clinical trials
October 02, 2008

An investigational drug for treating attention-deficit/hyperactivity disorder (ADHD) has demonstrated "significant reductions" in ADHD symptoms in... Read summary »

New ADHD drug Connexyn goes to FDA
October 02, 2008

Drugmaker Shire Plc has filed for approval from the Food and Drug Administration for a new attention-deficit/hyperactivity disorder (ADHD) drug.... Read summary »

Pharmacist: Doctors already knew about "new" ADHD drug risks
October 02, 2008

Amid controversy surrounding the way the Food and Drug Administration (FDA) handled recent changes to labels for attention-deficit/hyperactivity... Read summary »

New ADHD drug gets second-round approval from FDA
October 02, 2008

The U.S. Food and Drug Administration has given second-round approval to NRP104, a new medication for attention-deficit/hyperactivity disorder... Read summary »

New ADHD drug gets FDA nod
October 02, 2008

The Food and Drug Administration (FDA) has issued an approval letter for NRP104, a new drug to treat attention-deficit/hyperactivity disorder (ADHD).... Read summary »